Abbott Test Can Be Used to Predict Death, Disability for Patients With TBI, Study Finds
The researchers studied the value of testing patients with traumatic brain injury for the GFAP and UCH-L1 markers using Abbott Labs' point-of-care i-STAT Alinity System.
The company is assessing a variety of applications, including cancer early detection, using algorithms to analyze orphan noncoding RNA in blood.
IDbyDNA Nabs Additional Funding for Gene Editing Dx, Biosurveillance Tech
In collaboration with other firms, IDbyDNA is using precision metagenomics to develop a next-generation device for diagnostic testing of emerging infectious diseases.
Metagenomic Infectious Disease Sequencing Test Repurposed for Cancer Detection From CSF Samples
The assay from a Stanford and UCSF team allows clinicians to scan for multiple cancers of the central nervous system and to reanalyze past samples.
The project, being coordinated by UCSF and the University of Heidelberg, has a total budget of $20 million and is expected to run through 2025.